Synthetic Biology Market Size & Analysis Report – Global Opportunities & Forecast, 2023-2030
Synthetic Biology Market Size & Analysis Report, By Type of Products (Core Product, Enabling Products), By Enabling Products (DNA Synthesis, Oligonucleotide Synthesis), By Technology (Genome Engineering, Bioinformatics, DNA sequencing, Biological Component and Integrated System, Mutagenesis), By Application (Healthcare, Agriculture, Chemical Industry, Pharmaceuticals, Industrial) and by Geography
1. Executive Summary
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Geographical Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
3. Global Synthetic Biology Market - Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Drivers
3.5. Restraints
3.6. Trends
4. Global Synthetic Biology as a Service Market Revenue Forecast till 2030
5. Global Synthetic Biology as a Service Market by Types of Product Revenue Forecast till 2030
5.1. Core Products
5.1.1. Synthetic DNA
5.1.2. Synthetic Genes
5.1.3. Synthetic Cells
5.1.4. Chassis organisms
5.1.5. XNO (Xeno Nucleic Acid)
5.2. Enabling Products
5.2.1. DNA Synthesis
5.2.2. Oligonucleotide Synthesis
6. Global Synthetic Biology as a Service Market by Technology Type Revenue Forecast till 2030
6.1. Genome Engineering
6.2. Bioinformatics
6.3. DNA sequencing
6.4. Biological Component and Integrated System
6.5. Mutagenesis
7. Global Synthetic Biology as a Service Market by Application Type Revenue Forecast till 2030
7.1. Healthcare
7.2. Agriculture
7.3. Chemical Industry
7.4. Pharmaceuticals
7.5. Industrial
8. Global Synthetic Biology as a Service Market by Geography Revenue Forecast till 2030
8.1. Europe Synthetic Biology as a Service Market Revenue Forecast till 2030 (Option 1: 25% customization)
8.1.1. Europe Synthetic Biology as a Service Market by Types of Products
8.1.1.1. Core Products
8.1.1.1.1. Synthetic DNA
8.1.1.1.2. Synthetic Genes
8.1.1.1.3. Synthetic Cells
8.1.1.1.4. Chassis organisms
8.1.1.1.5. XNO (Xeno Nucleic Acid)
8.1.1.2. Enabling Products
8.1.1.2.1. DNA Synthesis
8.1.1.2.2. Oligonucleotide Synthesis
8.1.2. Europe Synthetic Biology as a Service Market by Technology
8.1.2.1. Genome Engineering
8.1.2.2. Bioinformatics
8.1.2.3. DNA sequencing
8.1.2.4. Biological Component and Integrated System
8.1.2.5. Mutagenesis
8.1.3. Europe Synthetic Biology as a Service Market by Application
8.1.3.1. Healthcare
8.1.3.2. Agriculture
8.1.3.3. Chemical Industry
8.1.3.4. Pharmaceuticals
8.1.3.5. Industrial
8.2. North America Synthetic Biology as a Service Market Revenue Forecast till 2030(Option 2: 25% customization)
8.2.1. North America Synthetic Biology as a Service Market by Types of Products
8.2.1.1. Core Products
8.2.1.1.1. Synthetic DNA
8.2.1.1.2. Synthetic Genes
8.2.1.1.3. Synthetic Cells
8.2.1.1.4. Chassis organisms
8.2.1.1.5. XNO (Xeno Nucleic Acid)
8.2.1.2. Enabling Products
8.2.1.2.1. DNA Synthesis
8.2.1.2.2. Oligonucleotide Synthesis
8.2.2. North America Synthetic Biology as a Service Market by Technology
8.2.2.1. Genome Engineering
8.2.2.2. Bioinformatics
8.2.2.3. DNA sequencing
8.2.2.4. Biological Component and Integrated System
8.2.2.5. Mutagenesis
8.2.3. North America Synthetic Biology as a Service Market by Application
8.2.3.1. Healthcare
8.2.3.2. Agriculture
8.2.3.3. Chemical Industry
8.2.3.4. Pharmaceuticals
8.2.3.5. Industrial
8.3. Asia-Pacific Synthetic Biology as a Service Market Revenue Forecast till 2030 (Option 3: 25% customization)
8.3.1. Asia-Pacific Synthetic Biology as a Service Market by Types of Products
8.3.1.1. Core Products
8.3.1.1.1. Synthetic DNA
8.3.1.1.2. Synthetic Genes
8.3.1.1.3. Synthetic Cells
8.3.1.1.4. Chassis organisms
8.3.1.1.5. XNO (Xeno Nucleic Acid)
8.3.1.2. Enabling Products
8.3.1.2.1. DNA Synthesis
8.3.1.2.2. Oligonucleotide Synthesis
8.3.2. Asia-Pacific Synthetic Biology as a Service Market by Technology
8.3.2.1. Genome Engineering
8.3.2.2. Bioinformatics
8.3.2.3. DNA sequencing
8.3.2.4. Biological Component and Integrated System
8.3.2.5. Mutagenesis
8.3.3. Asia-Pacific Synthetic Biology as a Service Market by Application
8.3.3.1. Healthcare
8.3.3.2. Agriculture
8.3.3.3. Chemical Industry
8.3.3.4. Pharmaceuticals
8.3.3.5. Industrial
8.4. Rest of the world Synthetic Biology as a Service Market Revenue Forecast till 2030 (Option 4: 25% customization)
8.4.1. Rest of the world Synthetic Biology as a Service Market by Types of Products
8.4.1.1. Core Products
8.4.1.1.1. Synthetic DNA
8.4.1.1.2. Synthetic Genes
8.4.1.1.3. Synthetic Cells
8.4.1.1.4. Chassis organisms
8.4.1.1.5. XNO (Xeno Nucleic Acid)
8.4.1.2. Enabling Products
8.4.1.2.1. DNA Synthesis
8.4.1.2.2. Oligonucleotide Synthesis
8.4.2. Rest of the world Synthetic Biology as a Service Market by Technology
8.4.2.1. Genome Engineering
8.4.2.2. Bioinformatics
8.4.2.3. DNA sequencing
8.4.2.4. Biological Component and Integrated System
8.4.2.5. Mutagenesis
8.4.3. Rest of the world Synthetic Biology as a Service Market by Application
8.4.3.1. Healthcare
8.4.3.2. Agriculture
8.4.3.3. Chemical Industry
8.4.3.4. Pharmaceuticals
8.4.3.5. Industrial
9. Competitive Landscape
9.1. Porter 5 Analysis
9.2. Major players and their key strategies
9.3. Company Share Analysis
10. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
10.1. Novozymes
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Recent Developments
10.2. Merck KGaA
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Recent Developments
10.3. Intrexon Corporation
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Recent Developments
10.4. Agilent Technologies
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Recent Developments
10.5. Thermo Fischer Scientific
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Recent Developments
10.6. Integrated DNA technologies
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Recent Developments
10.7. Eurofins Scientific, Inc.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Recent Developments
10.8. Origene technologies
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Recent Developments
10.9. Scientific genomics Inc.
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Recent Developments
10.10. Editas Medicine, Inc.
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Recent Developments
10.11. Pareto Biotechnologies
10.11.1. Company Overview
10.11.2. Financials
10.11.3. Recent Developments
10.12. Twist biosciences
10.12.1. Company Overview
10.12.2. Financials
10.12.3. Recent Developments
10.13. Syntrox Inc.
10.13.1. Company Overview
10.13.2. Financials
10.13.3. Recent Developments
10.14. Sigma-Aldrich Co. LLC.
10.14.1. Company Overview
10.14.2. Financials
10.14.3. Recent Developments
10.15. Amyris Biotechnologies
10.15.1. Company Overview
10.15.2. Financials
10.15.3. Recent Developments
10.16. Epoch Life Science Inc
10.16.1. Company Overview
10.16.2. Financials
10.16.3. Recent Developments
11. About GMI Research
- Published Date: Dec-2022
- Report Format: Excel/PPT
- Report Code: HM55A-00-0719
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Synthetic Biology Market Size & Analysis Report – Global Opportunities & Forecast, 2023-2030
$ 4,499.00 – $ 6,649.00
Why GMI Research
